Yet, the results obtained in our shRNA-mediated HER2 knockdown experiments suggest that this cell line is somewhat dependent on this signaling pathway, and ErbB2/HER2 signaling pathway can still be targeted to control the proliferation of this gastric cancer cell line. Here, ERBB2 is linked to gastric cancer.